Hedgeye 130/30 Equity ETF (HELS)

The Hedgeye 130/30 Equity ETF presents a classic case of a brand-new vehicle with zero historical performance data to evaluate. Because the security is newly listed, there is no multi-year price trajectory to assess whether the market has rewarded or punished the underlying strategy, forcing a neutral stance on the long-term outlook regardless of the manager's pedigree. The recent price action shows the fund trading near its 52-week lows, having failed to break out of the $22-$26 range despite recent launches of other Hedgeye products, suggesting initial capital flows have been tepid or the strategy is currently underperforming the broader market. While the 130/30 active extension strategy theoretically offers asymmetric upside, the lack of a track record means investors cannot yet distinguish between a temporary lag and a structural flaw in the execution. On the income front, the dividend is negligible, offering no cushion for volatility. Consequently, the instrument sits at a neutral crossroads: too new to recommend as a core holding, but not yet proven bad enough to avoid entirely.